Pitfalls of the healthy vaccinee effect - Authors' reply

Affiliations

¹ Department of Primary Health Care, University of Auckland, Auckland 1072, New Zealand. Electronic address: h.petousis-harris@auckland.ac.nz.
² Department of Primary Health Care, University of Auckland, Auckland 1072, New Zealand.
³ Sexual Health Services, Waikato District Health Board, Hamilton, New Zealand.
⁴ Department of Community Health, University of Auckland, Auckland 1072, New Zealand.
⁵ Department of Pediatrics, Global Health Center, Cincinnati Children's Hospital, Cincinnati, OH, USA.

Comment

Helen Petousis-Harris et al. Lancet. 2018.

. 2018 Jan 13;391(10116):123-124.

doi: 10.1016/S0140-6736(18)30018-7.

¹ Department of Primary Health Care, University of Auckland, Auckland 1072, New Zealand. Electronic address: h.petousis-harris@auckland.ac.nz.
² Department of Primary Health Care, University of Auckland, Auckland 1072, New Zealand.
³ Sexual Health Services, Waikato District Health Board, Hamilton, New Zealand.
⁴ Department of Community Health, University of Auckland, Auckland 1072, New Zealand.
⁵ Department of Pediatrics, Global Health Center, Cincinnati Children's Hospital, Cincinnati, OH, USA.

No abstract available

Comment on

Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study.
Petousis-Harris H, Paynter J, Morgan J, Saxton P, McArdle B, Goodyear-Smith F, Black S. Petousis-Harris H, et al. Lancet. 2017 Sep 30;390(10102):1603-1610. doi: 10.1016/S0140-6736(17)31449-6. Epub 2017 Jul 10. Lancet. 2017. PMID: 28705462 Clinical Trial.
Pitfalls of the healthy vaccinee effect.
Mahmud SM, Righolt CH. Mahmud SM, et al. Lancet. 2018 Jan 13;391(10116):123. doi: 10.1016/S0140-6736(18)30017-5. Lancet. 2018. PMID: 29353621 No abstract available.